<VariationArchive VariationID="419141" VariationName="NM_152490.5(B3GALNT2):c.770dup (p.Ala259fs)" VariationType="Duplication" Accession="VCV000419141" Version="5" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-20" DateCreated="2017-04-27" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="405084" VariationID="419141">
      <GeneList>
        <Gene Symbol="B3GALNT2" FullName="beta-1,3-N-acetylgalactosaminyltransferase 2" GeneID="148789" HGNC_ID="HGNC:28596" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q42.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="235439796" stop="235504452" display_start="235439796" display_stop="235504452" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NW_014040927.1" start="83388" stop="148044" display_start="83388" display_stop="148044" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="235610532" stop="235667780" display_start="235610532" display_stop="235667780" Strand="-" />
          </Location>
          <OMIM>610194</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_152490.5(B3GALNT2):c.770dup (p.Ala259fs)</Name>
      <CanonicalSPDI>NC_000001.11:235465706:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1q42.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="235465706" stop="235465707" display_start="235465706" display_stop="235465707" variantLength="1" positionVCF="235465706" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="235629023" stop="235629024" display_start="235629023" display_stop="235629024" variantLength="1" positionVCF="235629023" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
      </Location>
      <ProteinChange>A300fs</ProteinChange>
      <ProteinChange>A259fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.235629024dup" Assembly="GRCh37">
            <Expression>NC_000001.10:g.235629024dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.235465707dup" Assembly="GRCh38">
            <Expression>NC_000001.11:g.235465707dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033219.2" sequenceAccession="NG_033219" sequenceVersion="2" change="g.43775dup">
            <Expression>NG_033219.2:g.43775dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001277155.3" sequenceAccession="NM_001277155" sequenceVersion="3" change="c.893dup">
            <Expression>NM_001277155.3:c.893dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001264084.1" sequenceAccession="NP_001264084" sequenceVersion="1" change="p.Ala300fs">
            <Expression>NP_001264084.1:p.Ala300fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_152490.5" sequenceAccession="NM_152490" sequenceVersion="5" change="c.770dup" MANESelect="true">
            <Expression>NM_152490.5:c.770dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_689703.1" sequenceAccession="NP_689703" sequenceVersion="1" change="p.Ala259fs">
            <Expression>NP_689703.1:p.Ala259fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_152490.2" sequenceAccession="NM_152490" sequenceVersion="2" change="c.770dupA">
            <Expression>NM_152490.2:c.770dupA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA16617087" DB="ClinGen" />
        <XRef Type="rs" ID="1064793673" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_152490.5(B3GALNT2):c.770dup (p.Ala259fs) AND not provided" Accession="RCV000484984" Version="3">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-06-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_152490.5(B3GALNT2):c.770dup (p.Ala259fs) AND Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11" Accession="RCV003574776" Version="1">
        <ClassifiedConditionList TraitSetID="9507">
          <ClassifiedCondition DB="MedGen" ID="C3554638">Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-09-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-09-26" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2017-04-27" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23453667</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9507" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17747" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11</ElementValue>
                <XRef ID="MONDO:0014071" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A11</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 11</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, B3GALNT2-RELATED</ElementValue>
                <XRef Type="MIM" ID="615181" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MDDGA11</ElementValue>
                <XRef Type="MIM" ID="615181" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15915" />
                <XRef ID="15915" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="588" DB="Orphanet" />
              <XRef ID="899" DB="Orphanet" />
              <XRef ID="C3554638" DB="MedGen" />
              <XRef ID="MONDO:0014071" DB="MONDO" />
              <XRef Type="MIM" ID="615181" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1101852" SubmissionDate="2022-06-08" DateLastUpdated="2023-03-04" DateCreated="2017-04-27">
        <ClinVarSubmissionID localKey="GDXSV:229731" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000566745" DateUpdated="2023-03-04" DateCreated="2017-04-27" Type="SCV" Version="5" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="B3GALNT2" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:429124</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_152490.2:c.770dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_111_20220608054204</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8054589" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="5226027|MedGen:C3554638" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004369778" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23453667</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ala259Cysfs*5) in the B3GALNT2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in B3GALNT2 are known to be pathogenic (PMID: 23453667). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with B3GALNT2-related conditions. ClinVar contains an entry for this variant (Variation ID: 419141). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="B3GALNT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.235629023_235629024insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3554638" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8054589" TraitType="Disease" MappingType="XRef" MappingValue="C3554638" MappingRef="MedGen">
        <MedGen CUI="C3554638" Name="Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1101852" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

